HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zsolt Szakonyi Selected Research

Esters

8/2011Monoterpene-based chiral β-amino acid derivatives prepared from natural sources: syntheses and applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zsolt Szakonyi Research Topics

Disease

7Neoplasms (Cancer)
10/2022 - 08/2011
1Ovarian Neoplasms (Ovarian Cancer)
06/2023
1Hemolysis
06/2019
1Adenocarcinoma
10/2017
1Schistosomiasis (Bilharziasis)
10/2017
1Carcinoma (Carcinomatosis)
10/2017
1Inflammation (Inflammations)
01/2004
1Experimental Arthritis
01/2004
1Parkinsonian Disorders (Parkinsonism)
07/2003
1Parkinson Disease (Parkinson's Disease)
07/2003
1Movement Disorders (Movement Disorder)
07/2003

Drug/Important Bio-Agent (IBA)

12-aminopyrimidineIBA
06/2023
1Monoterpenes (Monoterpenoids)IBA
06/2023
12,4-diaminopyridineIBA
10/2022
1PyrimidinesIBA
10/2022
1aniline (aniline hydrobromide)IBA
10/2022
1Cisplatin (Platino)FDA LinkGeneric
05/2022
1steviolIBA
12/2019
12,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
06/2019
12,2'-azobis(2-amidinopropane) (ABAP)IBA
06/2019
1AntioxidantsIBA
06/2019
1Cholinesterases (Cholinesterase)IBA
06/2019
1EnzymesIBA
06/2019
1Hydroxyl RadicalIBA
06/2019
1isopulegolIBA
11/2018
1Antiparasitic Agents (Antiparasitics)IBA
10/2017
1OxazinesIBA
10/2017
1Praziquantel (Biltricide)FDA Link
10/2017
1SchistosomicidesIBA
10/2017
1caraneIBA
10/2014
1ThioureaIBA
08/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2011
1EstersIBA
08/2011
1AlcoholsIBA
01/2004
1Amine Oxidase (Copper-Containing)IBA
01/2004
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
07/2003